Deep Intelligence Across Industries

Company Headquarters: Yokohama, Japan Founded: 1942 Workforce: ~2,364 Company Working: Sakata Seed Corporation (Sakata) produces and sells vegetable seeds, flower seeds, grass seeds, vegetable seedlings, flower seedlings, bulbs, and agricultural/gardening materials in Japan and other parts of the globe. It is also engaged in the publication of gardening literature; R&D and contract production of seeds; and the design, management, and contract of various constructions, such as landscaping, greenhouse, and agricultural facilities. It offers okra seeds through its subsidiary Sakata Seed America. The company was formerly known as T. Sakata & Company and changed its name in January 1986.

Company Headquarters: Basel, Switzerland Founded: 2000 Workforce: ~30,000 Company Working: Syngenta AG is an agribusiness company involved in the manufacturing and marketing of agrochemical products. The company operates in the crop protection, seeds, and professional solutions market. It is one of the leading companies in crop protection products (herbicides, fungicides, nematicides, and seed treatments) that help farmers maximize harvests. It also supplies high-yield GMO seeds for field crops, vegetables, and flowers. A smaller part of the business comprises lawn, turf, landscaping, and professional pest management products. Syngenta's largest market in Latin America, but its major brands—including Agrisure, NK oilseeds, and Golden Harvest—are sold around the world. In addition, Syngenta is organized on a worldwide basis into five operating segments, which have been aggregated into the global crop protection segment, including Professional Solutions (previously known as Controls) and the global seeds segment, which covers field crops, vegetables, and flowers. The crop protection segment develops and produces herbicides, insecticides, fungicides, seed treatments, and biocontrols that promote strong and healthy plant growth. The seeds segment offers a broad portfolio of crops with particular strengths in corn, soybean, sunflower, cereals, and vegetables. Moreover, the company has acquired the ADAMA agric company which deals in nematicide crop protection products.

Company Headquarters: New Jersey, US Founded: 2014 Workforce: ~500 Company Working: Legend Biotech is a multinational biopharmaceutical company. The company has three core cell therapy platforms—CAR-T) T-cell receptor T-cell therapy (TCR-T), and allogeneic cell therapy. The company has been developing a strong pipeline of CAR-T products to treat solid and liquid tumors. Legend Biotech is utilizing the extensive cell therapy experience of its leaders and R & D staff, global clinical partners, and expanding research facilities. It is doing so to utilize the potential of cell therapy to treat diseases that are thought to be incurable, such as hematologic malignancies, solid tumors, infectious diseases, and autoimmune diseases

Company Headquarters: Washington, US Founded: 2013 Workforce: ~500 (2016) Company Working: Juno Therapeutics is a part of Celgene Corporation. It is a biopharmaceutical company formed through the collaboration of Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. The company is into the development of cell-based cancer immunotherapies based on chimeric antigen receptor (CAR) and high-affinity T cell receptor technologies to genetically engineer T cells to recognize and kill cancer. Juno Therapeutics is developing multiple cell-based product candidates to treat a variety of B-cell malignancies as well as multiple solid tumors and multiple myeloma. The company has its offices in the US and Germany. The company has its manufacturing plant in Washington, US.

Company Headquarters: France, Paris Founded: 1999 Workforce: ~161 Company Working: Cellectis is a clinical stage biotechnological company involved in the development of immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. The company operates through two segments—Therapeutics and Plants. Cellectis is currently developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia (ALL), UCART22 to treat ALL and non-Hodgkin lymphoma (NHL), ALLO-501 for treating relapsed/refractory NHL, and UCART123 for the treatment of acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm, among others

Company Headquarters: Darmstadt, Germany Founded: 1668 Workforce: ~60,348 Company Working: Merck KGaA (Merck) is a pharmaceutical company that offers a varied range of products subgrouped into three segments—healthcare, life sciences, and performance materials. The company delivers innovative health solutions and is dedicated to providing breakthrough solutions and technologies. The company research drugs in the areas of oncology and neurodegenerative as well as autoimmune and inflammatory diseases. It also markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for industries such as pharmaceuticals, food, cosmetics, packaging, and coatings. It has expanded its global footprint through several mergers and acquisitions, such as the acquisition of Millipore and Sigma-Aldrich. The company is distributing its products in the following countries: China, India, Japan, Australia, Israel, United Arab Emirates, South Korea, Denmark, Italy, Netherlands, Spain, United Kingdom, Switzerland, Sweden, Argentina, Brazil, Canada, US, New Zealand among others.

Company Headquarters: Basel, Switzerland Founded: 1897 Workforce: ~15,375 Company Working: Lonza is engaged in the manufacturing and supply of oilfield biocides as well as pharmaceutical, healthcare, and life science products. It operates through the pharma & biotech, specialty ingredients, and corporate segments. The specialty ingredients segment consists of two divisions, consumer health and consumer resources and protection. The pharma & biotech segment comprises the development and manufacturing of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources.

Company Headquarters: US Founded: 1991 Workforce: 13,755+ Company Working: Gentherm is a global technology and industry leader in designing, developing, and manufacturing innovative thermal management technologies. Its products provide solutions for automotive passenger comfort and convenience, battery thermal management, remote power generation, patient temperature management, and other consumer and industrial temperature control needs. Gentherm’s automotive products can be found on the vehicles of nearly all major automotive manufacturers operating in North America, Europe, and Asia. The company identifies future thermal technology product opportunities in both automotive and other markets. It concentrates research on the development of new technologies and new applications from existing technologies to create product and market opportunities for a wide array of thermal management solutions.

Company Headquarters: Zürich, Switzerland Founded: 1996 Workforce: 10,001+ Company Working: Barry Callebaut is a cocoa processor and chocolate manufacturer. Its work is divided into cocoa products, products for food & beverage manufacturers, and gourmet & specialties. The company also offers customized solutions for multiple domains like bakery, savory, confectionery, and ice cream & desserts. It has a presence in multiple regions, and the working of the company is divided into Europe, Middle East & Africa, the Americas, and Asia-Pacific. The global cocoa segment is reported separately as a region.